SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-041500
Filing Date
2024-10-18
Accepted
2024-10-18 08:30:10
Documents
14
Period of Report
2024-10-18
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 40814
2 ex99-1.htm EX-99.1 7534
  Complete submission text file 0001493152-24-041500.txt   225132

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE ogen-20241018.xsd EX-101.SCH 3018
4 XBRL LABEL FILE ogen-20241018_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE ogen-20241018_pre.xml EX-101.PRE 24167
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3659
Mailing Address 1990 MAIN STREET SUITE 750 SARASOTA FL 34236
Business Address 1990 MAIN STREET SUITE 750 SARASOTA FL 34236 8132867900
ORAGENICS INC (Filer) CIK: 0001174940 (see all company filings)

IRS No.: 593410522 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32188 | Film No.: 241378930
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)